Company intelligence / Profile preview

Meadowhawk Biolabs

Marlborough, Massachusetts, United Statesmeadowhawkbiolabs.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Meadowhawk Biolabs provides preclinical contract research services including LCMS bioanalysis, rodent in vivo pharmacokinetic/pharmacodynamic studies, and immunoanalytical assays. It supports small and large molecule modalities for biotech and pharma clients to advance drug discovery from exploratory through IND-enabling stages. The company operates AAALAC-accredited vivarium facilities near Boston and San Francisco.

Modalities: Small moleculePeptidesProteinsMonoclonal antibodyAntibody-drug conjugateNucleotides (including oligonucleotides)Lipid nanoparticle delivery therapy
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Meadowhawk Biolabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meadowhawk Biolabs.

Explore the full profile